UBS Group »

Cg Oncology shares owned by UBS Group

Quarter-by-quarter ownership of Cg Oncology shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Cg Oncology

Tip: Access up to 7 years of quarterly data

All positions including Cg Oncology held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cg Oncology by UBS Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.0M 23k 43.90

More positions owned by UBS Group

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Amazon Call Option (AMZN)
Ubs Group SHS Call Option (UBS)
JPMorgan Chase & Co. Call Option (JPM)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Visa Com Cl A Call Option (V)
Alphabet Cap Stk Cl C Call Option (GOOG)
UnitedHealth Call Option (UNH)

View all positions for UBS Group

Top funds holding Cg Oncology

BlackRock
Vanguard Group
BVF
Henderson Group
Avidity Partners Management
RA Capital Management
Perceptive Advisors
Braidwell
T. Rowe Price Associates
Franklin Resources
Cormorant Asset Management
Frazier Life Sciences Management
Holocene Advisors
T. Rowe Price Investment Management
Foresite Capital Management V

View all funds holding Cg Oncology